GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxcyte Inc (FRA:5VA) » Definitions » Accounts Payable

Vaxcyte (FRA:5VA) Accounts Payable : €46.27 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Vaxcyte Accounts Payable?

Vaxcyte's Accounts Payable for the quarter that ended in Dec. 2024 was €46.27 Mil.

Vaxcyte's quarterly Accounts Payable increased from Jun. 2024 (€9.72 Mil) to Sep. 2024 (€16.42 Mil) and increased from Sep. 2024 (€16.42 Mil) to Dec. 2024 (€46.27 Mil).

Vaxcyte's annual Accounts Payable increased from Dec. 2022 (€9.25 Mil) to Dec. 2023 (€13.38 Mil) and increased from Dec. 2023 (€13.38 Mil) to Dec. 2024 (€46.27 Mil).


Vaxcyte Accounts Payable Historical Data

The historical data trend for Vaxcyte's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxcyte Accounts Payable Chart

Vaxcyte Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial 24.48 5.98 9.25 13.38 46.27

Vaxcyte Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.38 19.98 9.72 16.42 46.27

Vaxcyte Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Vaxcyte Accounts Payable Related Terms

Thank you for viewing the detailed overview of Vaxcyte's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaxcyte Business Description

Traded in Other Exchanges
Address
825 Industrial Road, Suite 300, San Carlos, CA, USA, 94070
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.

Vaxcyte Headlines

No Headlines